OncoCyte's market cap is currently $57.29M. The company's EPS TTM is $-4.43; its P/E ratio is ―; OncoCyte is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.50M	$ 958.00K	$ 7.73M	$ 1.22M	$ 0.00
Gross Profit	$ 413.00K	$ -18.00K	$ 188.00K	$ -639.00K	$ -344.00K
Operating Income	$ -25.14M	$ -18.00M	$ -46.95M	$ -29.71M	$ -22.24M
EBITDA	$ -23.12M	$ -13.31M	$ -48.46M	$ -30.54M	$ -21.89M
Net Income	$ -27.78M	$ -73.44M	$ -64.10M	$ -29.93M	$ -22.33M
Balance Sheet
Cash & Short-Term Investments	$ 9.43M	$ 20.43M	$ 36.51M	$ 7.82M	$ 22.45M
Total Assets	$ 74.89M	$ 100.09M	$ 159.56M	$ 55.42M	$ 39.86M
Total Debt	$ 2.87M	$ 3.54M	$ 5.68M	$ 8.63M	$ 5.94M
Net Debt	$ -6.56M	$ -16.45M	$ -29.93M	$ 1.49M	$ -16.14M
Total Liabilities	$ 49.30M	$ 65.80M	$ 94.35M	$ 21.94M	$ 9.02M
Stockholders' Equity	$ 25.59M	$ 34.29M	$ 65.22M	$ 33.48M	$ 30.84M
Cash Flow
Free Cash Flow	$ -23.61M	$ -49.91M	$ -38.19M	$ -27.21M	$ -20.63M
Operating Cash Flow	$ -23.32M	$ -45.57M	$ -35.94M	$ -25.98M	$ -19.71M
Investing Cash Flow	$ -932.00K	$ -4.34M	$ -13.96M	$ -11.75M	$ -12.41M
Financing Cash Flow	$ 12.19M	$ 35.81M	$ 78.36M	$ 22.80M	$ 47.87M

Currency in USD

OncoCyte Earnings and Revenue History

Income Statement >

OncoCyte Debt to Assets

Balance Sheet >

OncoCyte Cash Flow

Cash Flow >

OncoCyte Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing